-
DuChemBio clears MFDS for breast cancer PET diagnostic
19 Dec 2025 05:33 GMT
… MFDS) for its breast cancer diagnostic radiopharmaceutical, DuChemBio … treatment strategies.
In breast cancer, hormone receptor … biological characteristics of breast cancer,” adding, “By … the breast cancer diagnostic FES after the prostate cancer diagnostic …
-
Oral, lung cancers show sharpest rise in Delhi, breast cancer tops list: Ministry data
17 Dec 2025 02:00 GMT
… sharpest rise in Delhi, breast cancer tops list: Ministry data … 2023. In absolute terms, breast cancer remained the most prevalent cancer … that reported cases of breast cancer rose steadily from 3, … 1,814 in 2025. Prostate cancer also showed a steady upward …
-
Monte Rosa Therapeutics Announces Compelling Clinical Activity of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients with Androgen Receptor Mutations
16 Dec 2025 12:00 GMT
… with metastatic castration-resistant prostate cancer (mCRPC). MRT- … evolving treatment landscape of prostate cancer.” “While the … hormone receptor (HR)+ breast cancer. Data from this … tumors, including castration-resistant prostate cancer (CRPC). In heavily …
-
Signs and symptoms of prostate cancer YOU need to know – as Cliff Richard reveals diagnoses
15 Dec 2025 08:58 GMT
… ,526 women with breast cancer – the next most … get prostate cancer
The risk of developing prostate cancer … prostate cancer while exercising regularly lowers it.
Prostate Cancer … aggressive prostate cancer.
Celebrities diagnosed with prostate cancer
David …
-
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes
19 Dec 2025 08:28 GMT
… and requiring intensive treatment.19
Prostate cancer is the most prevalent … in People with SoC
Breast cancer and prostate cancer are the most diagnosed … hormones. Hormonal treatments for prostate cancer include luteinizing hormone-releasing hormone …
-
Zydus Signs Exclusive Pact with US-Based Myriad Genetics to Launch Cancer Diagnostic Tests in India
19 Dec 2025 12:06 GMT
… ovarian cancer, and the Prolaris® prostate cancer prognostic test, to clinicians and … estimate five-year and lifetime breast cancer risk, enabling personalised screening and …
-
Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 09:31 GMT
… Deficiency (HRD) Test and Prolaris® Prostate Cancer Prognostic Test to patients, clinicians … and Prolaris® a gene expression Prostate Cancer Prognostic Test.
These tests have … predict 5-year and lifetime breast cancer risk, enabling individualised screening …
-
Oncologist says common pill increases cancer risk up to 30 per cent
19 Dec 2025 11:20 GMT
… other cancers such as prostate cancer, bowel cancer, and breast cancer, the charity added … rates of lung cancer, prostate cancer, bowel cancer, and breast cancer.
The risk is …
-
8 cancer-fighting foods you should add to your daily diet
19 Dec 2025 12:07 GMT
… of oestrogen receptor-negative (ER-) breast cancer. CarrotsCarrots have cancer-fighting potential … to a lower risk of prostate cancer, but the evidence for this …
-
Zydus partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 08:49 GMT
… Deficiency (HRD) Test and Prolaris Prostate Cancer Prognostic Test to patients, clinicians … and Prolaris a gene expression Prostate Cancer Prognostic Test.
These tests have … predict 5-year and lifetime breast cancer risk, enabling individualised screening and …
About
© 1995-2025